Company News in the Life Science Industry

»

Reset 

REVA Receives Interim Funding Commitment and Announces Leadership Changes

Read more ››
By: Nasdaq / GlobenewsWire - 25 Mar 2019

Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign to Highlight QBREXZA™ (glycopyrronium) Cloth

Read more ››
By: Nasdaq / GlobenewsWire - 25 Mar 2019
Related companies:  Dermira Inc.

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO

NEW ORLEANS, March 25, 2019 /PRNewswire/ -- Oral semaglutide 7 mg and 14 mg demonstrated superior HbA(1c) and body weight reductions compared to Januvia(®) (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA(1c) reductions at 26 weeks was not confirmed. Presented today at... Read more ››

By: PR Newswire Association LLC. - 25 Mar 2019

Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting

SYDNEY, March 25, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) has been selected to present data from the Phase I study of Cantrixil in ovarian cancer at the American Association for Cancer Research (AACR) 2019 Annual Meeting.

... Read more ››
By: PR Newswire Association LLC. - 25 Mar 2019

MediciNova Announces Upcoming Presentations Regarding the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive Multiple Sclerosis at the 71st American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania

Read more ››
By: Nasdaq / GlobenewsWire - 25 Mar 2019
Related companies:  MediciNova, Inc.

Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing

WALTHAM, Mass. and CAMBRIDGE, Mass., March 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, today announced they have entered into a definitive agreement... Read more ››

By: PR Newswire Association LLC. - 25 Mar 2019
Related companies:  Thermo Fisher Scientific Inc.

Society of Interventional Radiology Foundation bestows annual philanthropy award

AUSTIN, Texas, March 24, 2019 /PRNewswire/ -- The Society of Interventional Radiology Foundation presented this year's Frederick S. Keller, M.D., Philanthropy Award to John Abele, FSIR at the foundation's annual Gala on March 24, held in conjunction with the Society of Interventional... Read more ››

By: PR Newswire Association LLC. - 24 Mar 2019

Ascendis Pharma Announces Phase 3 heiGHt Trial Demonstrated Superior Efficacy and Comparable Safety and Tolerability of TransCon™ hGH to a Daily Growth Hormone

Read more ››
By: Nasdaq / GlobenewsWire - 24 Mar 2019
Related companies:  Ascendis Pharma A/S

Alan H. Matsumoto, M.D., FSIR, debuts the GEMS Program at SIR 2019

AUSTIN, Texas, March 24, 2019 /PRNewswire/ -- Former Society of Interventional Radiology (SIR) President Alan H. Matsumoto, M.D., FSIR, introduced a new program to support diversity in interventional radiology by providing a travel grant for medical students from diverse backgrounds who desire... Read more ››

By: PR Newswire Association LLC. - 24 Mar 2019

Society of Interventional Radiology 2019 Gold Medalists exemplify outstanding achievement in interventional radiology

AUSTIN, Texas, March 24, 2019 /PRNewswire/ -- The Society of Interventional Radiology (SIR) presented its... Read more ››

By: PR Newswire Association LLC. - 24 Mar 2019

Alan H. Matsumoto, M.D., FSIR encourages IR unity during Dotter Lecture at SIR 2019

AUSTIN, Texas, March 24, 2019 /PRNewswire/ -- Interventional radiologists must work as a group to make the practice of medicine more patient-centric and efficient, said Alan H. Matsumoto, M.D., FSIR, who delivered the Read more ››

By: PR Newswire Association LLC. - 24 Mar 2019

Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit

BEIJING, March 24, 2019 /PRNewswire/ -- Sanofi Chief Executive Officer Olivier Brandicourt expressed yesterday that he is very glad to be able to participate in the 2019 edition of the China Development Forum, particularly as it marks the 20(th) anniversary of the Forum.

Read more ››
By: PR Newswire Association LLC. - 24 Mar 2019

Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 23 Mar 2019
Related companies:  Radius Health, Inc.

Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR

RUSSELLVILLE, Ark., March 23, 2019 /PRNewswire/ -- Grifols is pleased to announce the opening of a new Biotest plasma donor center located at 1105 W Main Street, Russellville, Arkansas. The 15,000 square foot state-of-the-art facility officially opened its doors for business on March 22, 2019.... Read more ››

By: PR Newswire Association LLC. - 23 Mar 2019
Related companies:  Grifols USA, LLC | Grifols Biologicals Inc. | Grifols Therapeutics, Inc.

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO

NEW ORLEANS, March 23, 2019 /PRNewswire/ -- Oral semaglutide 7 mg and 14 mg demonstrated superior A1C and body weight reductions compared to Januvia(®) (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for A1C reduction at 26 weeks was not confirmed. Presented today at the Endocrine... Read more ››

By: PR Newswire Association LLC. - 23 Mar 2019
Related companies:  Novo Nordisk Inc.

Sojournix Poster Presentation At ENDO 2019 Features Positive Data From SJX-653 Proof-of-Mechanism Clinical Study

WALTHAM, Mass., March 23, 2019 /PRNewswire/ -- Sojournix, a clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative new medicines for the treatment of women's health and neuroendocrine disorders, today presented positive data from a first-in-human Phase... Read more ››

By: PR Newswire Association LLC. - 23 Mar 2019
Related companies:  Sojournix Inc.

$17.3 Bn Stem Cell Banking Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

DUBLIN, March 22, 2019 /PRNewswire/ -- The "Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's... Read more ››

By: PR Newswire Association LLC. - 23 Mar 2019

Watchdog Group, CCHR, to OBGYN Conference: Prevent Psychiatric Drugging of the Preborn

BOSTON, March 22, 2019 /PRNewswire/ -- Psychiatric watchdog, Citizens Commission on Human Rights... Read more ››

By: PR Newswire Association LLC. - 23 Mar 2019

Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Recro Pharma, Inc.

Tecan to vertically integrate supplier of key parts

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies